Data / Form D filings / PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc: Form D filings
PhaseBio Pharmaceuticals Inc, a pharmaceuticals company in Malvern, PA, filed 8 Form D notices with the SEC between 2009 and 2018. The latest, on September 10, 2018, reports $26 million sold of a $32.1 million offering to 20 investors.
Find out what PhaseBio Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- One Great Valley Parkway, Suite30, Malvern, PA, 19355
- Phone
- (610) 981-6500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1169245
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2018 | New notice | $32,125,000 | $25,998,130 | $6,126,870 | 20 | Aug 27, 2018 | sec.gov |
| Jan 31, 2017 | New notice | $7,875,000 | $6,615,000 | $1,260,000 | 9 | Jan 17, 2017 | sec.gov |
| Jul 21, 2015 | Amendment | $42,000,000 | $21,000,000 | $21,000,000 | 9 | Feb 26, 2015 | sec.gov |
| Mar 12, 2015 | New notice | $40,000,000 | $20,000,000 | $20,000,000 | 8 | Feb 26, 2015 | sec.gov |
| Jun 18, 2012 | Amendment | $48,524,067 | $48,524,067 | $0 | 17 | Dec 22, 2009 | sec.gov |
| Dec 6, 2010 | Amendment | $25,300,001 | $25,300,001 | $0 | 12 | Dec 22, 2009 | sec.gov |
| Jan 5, 2010 | New notice | $25,300,001 | $10,120,000 | $15,180,001 | 12 | Dec 22, 2009 | sec.gov |
| Nov 12, 2009 | New notice | $1,000,000 | $999,999 | $1 | 6 | Nov 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Mow | Executive Officer, Director | |
| Linda Tufts | Director | |
| Justin Klein | Director | |
| Clay Thorp | Director | |
| Bibhash Mukhopadhyay | Director | |
| John Sharp | Executive Officer | |
| Nancy Hutson | Director | |
| Caroline Loewy | Director | |
| Tyrell Rivers | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Sep 10, 2018 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PhaseBio Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.